Renal osteodystrophy with hyperphosphatemia

Renal osteodystrophy with hyperphosphatemia describes a complex metabolic bone disorder occurring in patients with advanced chronic kidney disease or end-stage renal disease, marked by concurrently elevated serum phosphorus levels This pathophysiologic cascade leads to aberrant bone remodeling—ranging from high-turnover osteitis fibrosa cystica to adynamic bone disease and osteomalacia—and markedly increases the risks of bone pain, pathologic fractures, and extraosseous calcification

Renal osteodystrophy with hyperphosphatemia describes a complex metabolic bone disorder occurring in patients with advanced chronic kidney disease or end-stage renal disease, marked by concurrently elevated serum phosphorus levels It primarily affects the skeletal and mineral endocrine systems as a consequence of impaired glomerular filtration and inadequate urinary phosphate excretion This pathophysiologic cascade leads to aberrant bone remodeling—ranging from high-turnover osteitis fibrosa cys...

It primarily affects the skeletal and mineral endocrine systems as a consequence of impaired glomerular filtration and inadequate urinary phosphate excretion The resulting phosphate retention, coupled with deficient renal production of calcitriol and secondary hypocalcemia, triggers secondary hyperparathyroidism and elevated fibroblast growth factor 23 This pathophysiologic cascade leads to aberrant bone remodeling—ranging from high-turnover osteitis fibrosa cystica to adynamic bone disease and ...

The resulting phosphate retention, coupled with deficient renal production of calcitriol and secondary hypocalcemia, triggers secondary hyperparathyroidism and elevated fibroblast growth factor 23